Showing 5701-5710 of 5956 results for "".
- Editas Medicine Announces FDA Acceptance of IND Application for LCA10 Treatment EDIT-101https://modernod.com/news/editas-medicine-announces-fda-acceptance-of-ind-application-for-lca10-treatment-edit-101/2476163/Editas Medicine announced that the FDA has accepted the company’s investigational new drug (IND) application for EDIT-101, an experimental CRISPR genome editing medicine being investigated for the treatment of Leber Congenital Amaurosis type 10 (LCA10). “The FDA’s acceptance of our IND for
- ProQR Announces Clearance of IND to Start Clinical Trial of QR-421a in Usher Syndrome Type 2 Patientshttps://modernod.com/news/proqr-announces-clearance-of-ind-to-start-clinical-trial-of-qr-421a-in-usher-syndrome-type-2-patients/2476165/ProQR Therapeutics announced that the FDA has cleared the investigational new drug (IND) application for QR-421a. QR-421a is a first-in-class investigational RNA-based oligonucleotide designed to address the underlying cause of the vision loss associated with Usher syndrome type 2 and non-syndrom
- Sangamo Announces Completion of TxCell Acquisitionhttps://modernod.com/news/sangamo-announces-completion-of-txcell-acquisition/2476169/Sangamo Therapeutics announced the completion of the acquisition of TxCell, which is now a subsidiary of Sangamo and has been delisted from the French stock market. “The acquisition of
- First Patient Successfully Implanted with Implandata’s Eye Pressure Sensor for Continual Glaucoma Monitoringhttps://modernod.com/news/first-patient-successfully-implanted-with-implandatas-eye-pressure-sensor-for-continual-glaucoma-monitoring/2476170/Ophthalmic medical device company Implandata Ophthalmic Products announced that the first patient in its international, multicenter, ARGOS-SC01 clinical study has been successfully implanted with its novel pressure sensor. This first-in-human clinical study is being conducted to validate the supr
- Bayer to Cut 12,000 Jobs, Exit Vet Unit Amid Drag From Suitshttps://modernod.com/news/bayer-to-cut-12000-jobs-exit-vet-unit-amid-drag-from-suits/2479631/Bayer announced Thursday that it will cut around 1,250 jobs from its pharmaceutical division as part of a wider staff-reduction plan that will lead to the loss of about 12,000 positions from its global workforce of 118,200 employees by the end of 2021. The streamlining is part of an overhaul unde
- EyeCare Partners Acquires Holcomb Laser Centerhttps://modernod.com/news/eyecare-partners-acquires-holcomb-laser-center/2479632/EyeCare Partners (ECP) furthered its expansion into the Alabama ophthalmology market with the acquisition of Dr. William Holcomb’s Cullman, Alabama-based Holcomb Laser Center, according to an announcement from EyeCare Partners, as reported in VisionMonday. Terms of the deal were not disclo
- Dry Eye Symptom Screens Show Modest Accuracyhttps://modernod.com/news/dry-eye-symptom-screens-show-modest-accuracy/2479636/In head-to-head comparisons, two of five dry eye screens showed a statistically significant ability to detect signs of the disorder, but all demonstrated relatively modest diagnostic accuracy, researchers say, according to a Reuters report
- Eyenovia Publishes PG21 Phase 2 Trial Results Examining IOP Lowering Effect and Patient Usabilityhttps://modernod.com/news/eyenovia-publishes-pg21-phase-2-trial-results-examining-iop-lowering-effect-and-patient-usability/2479637/Eyenovia announced that the full results of its phase 2 PG21 study have been published in the article “Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose” in the November issue of the peer-
- Lynx Inventory System Now Customized for Retina Specialistshttps://modernod.com/news/lynx-inventory-system-now-customized-for-retina-specialists/2479638/McKesson announced that Lynx, its customizable, cloud-based medication inventory management system for specialty medical practices, has new features designed especially for delivering injectable medication therapies in retina practices. These customizations for retina specialists ensure that each
- Glaucoma-Staging Systems May Underestimate Severityhttps://modernod.com/news/glaucoma-staging-systems-may-underestimate-severity/2479639/Standard automated perimetry (SAP) testing is often used to classify glaucoma severity but may fail to detect macular damage, according to New York City-based researchers, as reported in Reuters. “Because current staging syst